194 related articles for article (PubMed ID: 26448176)
1. Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark.
Rebolj M; Rask J; van Ballegooijen M; Kirschner B; Rozemeijer K; Bonde J; Rygaard C; Lynge E
Br J Cancer; 2015 Nov; 113(9):1259-74. PubMed ID: 26448176
[TBL] [Abstract][Full Text] [Related]
2. Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates.
Rozemeijer K; Penning C; Siebers AG; Naber SK; Matthijsse SM; van Ballegooijen M; van Kemenade FJ; de Kok IM
Cancer Causes Control; 2016 Jan; 27(1):15-25. PubMed ID: 26458884
[TBL] [Abstract][Full Text] [Related]
3. Comparison of SurePath® and ThinPrep® liquid-based cervical cytology using positive predictive value, atypical predictive value and total predictive value as performance indicators.
Wright PK; Marshall J; Desai M
Cytopathology; 2010 Dec; 21(6):374-8. PubMed ID: 20545727
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ThinPrep and SurePath liquid-based cytology and subsequent human papillomavirus DNA testing in China.
Zhao FH; Hu SY; Bian JJ; Liu B; Peck RB; Bao YP; Pan QJ; Frappart L; Sellors J; Qiao YL
Cancer Cytopathol; 2011 Dec; 119(6):387-94. PubMed ID: 21774094
[TBL] [Abstract][Full Text] [Related]
5. Performance of the CellSolutions Glucyte liquid-based cytology in comparison with the ThinPrep and SurePath methods.
Alaghehbandan R
Acta Cytol; 2013; 57(2):189-97. PubMed ID: 23407055
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study.
Rozemeijer K; Naber SK; Penning C; Overbeek LI; Looman CW; de Kok IM; Matthijsse SM; Rebolj M; van Kemenade FJ; van Ballegooijen M
BMJ; 2017 Feb; 356():j504. PubMed ID: 28196844
[No Abstract] [Full Text] [Related]
7. Sensitivity of high-risk HPV Hybrid Capture II (hrHPV HC2) test using SurePath(TM) specimens in the prediction of cervical high-grade squamous lesions.
Zhou F; Pulinthanathu R; Elgert P; Cangiarella J; Simsir A
Diagn Cytopathol; 2015 May; 43(5):381-7. PubMed ID: 25546355
[TBL] [Abstract][Full Text] [Related]
8. Artificial intelligence-assisted cytology for detection of cervical intraepithelial neoplasia or invasive cancer: A multicenter, clinical-based, observational study.
Bao H; Bi H; Zhang X; Zhao Y; Dong Y; Luo X; Zhou D; You Z; Wu Y; Liu Z; Zhang Y; Liu J; Fang L; Wang L
Gynecol Oncol; 2020 Oct; 159(1):171-178. PubMed ID: 32814641
[TBL] [Abstract][Full Text] [Related]
9. MAVARIC - a comparison of automation-assisted and manual cervical screening: a randomised controlled trial.
Kitchener HC; Blanks R; Cubie H; Desai M; Dunn G; Legood R; Gray A; Sadique Z; Moss S;
Health Technol Assess; 2011 Jan; 15(3):iii-iv, ix-xi, 1-170. PubMed ID: 21266159
[TBL] [Abstract][Full Text] [Related]
10. Liquid-based cytology: evaluation of effectiveness, cost-effectiveness, and application to present practice.
Cox JT
J Natl Compr Canc Netw; 2004 Nov; 2(6):597-611. PubMed ID: 19780303
[TBL] [Abstract][Full Text] [Related]
11. Comparison between Conventional Cytology and Liquid-Based Cytology in the Tertiary Brazilian Navy Hospital in Rio de Janeiro.
de Oliveira ACA; Domingues MF; Neufeld PM; Fleury M; Nogueira Neto JF
Acta Cytol; 2020; 64(6):539-546. PubMed ID: 32516778
[TBL] [Abstract][Full Text] [Related]
12. Impact of technology on cytology outcome in cervical cancer screening of young and older women.
Rask J; Lynge E; Franzmann M; Hansen B; Hjortebjerg A; Rygaard C; Schledermann D; Wåhlin A; Rebolj M
Int J Cancer; 2014 May; 134(9):2168-79. PubMed ID: 24122730
[TBL] [Abstract][Full Text] [Related]
13. A randomised comparison of SurePath liquid-based cytology and conventional smear cytology in a colposcopy clinic setting.
Sykes PH; Harker DY; Miller A; Whitehead M; Neal H; Wells JE; Peddie D
BJOG; 2008 Oct; 115(11):1375-81. PubMed ID: 18823488
[TBL] [Abstract][Full Text] [Related]
14. Altered recognition of reparative changes in ThinPrep specimens in the College of American Pathologists Gynecologic Cytology Program.
Snyder TM; Renshaw AA; Styer PE; Mody DR; Colgan TJ;
Arch Pathol Lab Med; 2005 Jul; 129(7):861-5. PubMed ID: 15974808
[TBL] [Abstract][Full Text] [Related]
15. Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma.
Hutchinson ML; Zahniser DJ; Sherman ME; Herrero R; Alfaro M; Bratti MC; Hildesheim A; Lorincz AT; Greenberg MD; Morales J; Schiffman M
Cancer; 1999 Apr; 87(2):48-55. PubMed ID: 10227593
[TBL] [Abstract][Full Text] [Related]
16. Morphologic analysis of false negative SurePath® slides using Focalpoint™ GS computer-assisted cervical screening technology: An Australian experience.
Bowditch RC; Clarke JM; Baird PJ; Greenberg ML
Diagn Cytopathol; 2015 Nov; 43(11):870-8. PubMed ID: 26174002
[TBL] [Abstract][Full Text] [Related]
17. A retrospective validation of the FocalPoint GS slide profiler NFR technology by analysis of interval disease outcomes compared with manual cytology.
Nuttall DS; Hillier S; Clayton HR; Savage AJ; Martin CM; O'Leary JJ
Cancer Cytopathol; 2019 Apr; 127(4):240-246. PubMed ID: 30825407
[TBL] [Abstract][Full Text] [Related]
18. A Multi-Institutional Feasibility Study on the Use of Automated Screening Systems for Quality Control Rescreening of Cervical Cytology.
Sugiyama Y; Sasaki H; Komatsu K; Yabushita R; Oda M; Yanoh K; Ueda M; Itamochi H; Okugawa K; Fujita H; Tase T; Nakatani E; Moriya T
Acta Cytol; 2016; 60(5):451-457. PubMed ID: 27673689
[TBL] [Abstract][Full Text] [Related]
19. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
20. [Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].
Ronco G; Confortini M; Maccallini V; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Giorgi Rossi P
Epidemiol Prev; 2012; 36(5 Suppl 2):e1-e33. PubMed ID: 23139163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
